the-so-called

By Ludwig Burger FRANKFURT (Reuters) – Germany is looking to encourage the development of more powerful antibiotics against the growing threat of drug-resistant superbugs, the country’s pharmaceutical industry association said on Wednesday. The health ministry in Berlin is to hold talks later this year with Germany’s pharma lobby VFA, which will propose loosely modeling any new rules for antibiotics on the so-called orphan drug status that is awarded to experimental treatments of rare diseases, VFA’s chairman Hagen Pfundner said.